在产后发育期间的KCC2激活缓解了CDKL5缺乏小鼠的长期缺陷
Muhammad Nauman Arshad1, Christopher Bope1, Noell Cho1
1Department of Neuroscience, Tufts University School of Medicine, Boston, MA, USA.
Experimental & molecular medicine
|February 18, 2026
概括
提高化携带体 (KCC2) 功能可能治疗循环素依赖类激酶5 (CDKL5) 缺乏症 (CDD). 在小鼠模型中,生命早期的KCC2激活减少了发作,改善了认知和行为缺陷.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环素依赖性酶类5 (CDKL5) 缺乏障碍 (CDD) 导致严重的早期和发育障碍.
- 目前的CDD治疗方法有限,对行为问题缺乏有效性,并引起副作用.
- 化携运输体 (KCC2) 在CDD中对抑制性神经传递至关重要,其作用尚不清楚.
研究的目的:
- 在CDD的小鼠模型中调查KCC2功能障碍.
- 评估KCC2激活在CDD中的治疗潜力.
主要方法:
- 使用了一个构成Cdkl5淘汰赛的老鼠模型.
- 采用液体染色学-双重质谱法进行无偏的KCC2酸化分析.
- 在关键发育窗口 (产后10-21天) 中服用KCC2激活剂 (OV350)
主要成果:
- 在CDD小鼠中观察到异常的KCC2酸化和减少表达,表明KCC2活性受损.
- 在出生后的第14天和第21天之间,KCC2表达和酸化发生了显著的改变.
- OV350治疗减少了婴儿,并在成年后降低了发作易感性和改善了认知/行为缺陷.
结论:
- KCC2功能障碍与CDD病理生理学有关.
- 在早期发育过程中增强KCC2功能,为CDD提供了一个有前途的治疗策略.
- 这种方法也可能有利于其他发育性和性脑病变.
相关概念视频
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Separation of Sister Chromatids
4.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.6K


